Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2

• Tamara Kusay Jabbar,

  Affiliation The Pirbright Institute, Pirbright, Woking, Surrey, United Kingdom

  ⨯
• Eva Calvo-Pinilla ,

  * E-mail: eva.calvo-pinilla@pirbright.ac.uk

  Affiliation The Pirbright Institute, Pirbright, Woking, Surrey, United Kingdom

  ⨯
• Francisco Mateos,

  Affiliation Centro en Investigación y Sanidad Animal, Valdeolmos, Madrid, Spain

  ⨯
• Simon Gubbins,

  Affiliation The Pirbright Institute, Pirbright, Woking, Surrey, United Kingdom

  ⨯
• Abdelghani Bin-Tarif,

  Affiliation The Pirbright Institute, Pirbright, Woking, Surrey, United Kingdom

  ⨯
• Katarzyna Bachanek-Bankowska,

  Affiliation The Pirbright Institute, Pirbright, Woking, Surrey, United Kingdom

  ⨯
• Oya Alpar,

  Affiliation Centre for Drug Delivery Research, London School of Pharmacy, London, United Kingdom

  ⨯
• Javier Ortego,

  Affiliation Centro en Investigación y Sanidad Animal, Valdeolmos, Madrid, Spain

  ⨯
• Haru-Hisa Takamatsu,

  Affiliation The Pirbright Institute, Pirbright, Woking, Surrey, United Kingdom

  ⨯
• Peter Paul Clement Mertens,

  Affiliation The Pirbright Institute, Pirbright, Woking, Surrey, United Kingdom

  ⨯
• Javier Castillo-Olivares

  Affiliation The Pirbright Institute, Pirbright, Woking, Surrey, United Kingdom

  ⨯